Key facts: GSK plans to invest $30 billion in U.S. research and development and supply chain infrastructure over the next five years.
Meno di 1 minuto di lettura
- GSK plans to invest $30 billion in U.S. research and development and supply chain infrastructure over the next five years.1
- In Q2 2025, GlaxoSmithKline's revenue fell to Rs 805.17 Crore, with a net profit of Rs 205.01 Crore. Annual revenue for 2025 rose to Rs 3,749.21 Crore.2
- On September 25, 2025, GSK will face a 10% tariff on branded drug imports, following an agreement with Prime Minister Keir Starmer, unlike the 100% tariff from President Trump starting October 1.3